Amiram, D, Kimmelman, E. The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices. 2nd ed. Milwaukee, WI: ASQ Quality Press, 2008.
Annas, G J, Elias, S. Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century. Am J Public Health 1999; 89(1): 98–101.
Burd, E M. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev 2010; 23(3): 550–576.
Criado, F J. Off-label use of devices: friend or foe? J Endovasc Ther 2006; 13(4): 505–506.
Curfman, G D, Redberg, R F. Medical devices – balancing regulation and innovation. N Engl J Med 2011; 365(11): 975–977.
Felten, R P, Ogdne, N R, Pena, C, et al. Food and Drug Administration medical device review process: clearance of a clot retriever for use in ischemic stroke. Stroke 2005; 36(2): 404–406.
Holbein, M E, Berglund, J P. Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators. J Investig Med 2012; 60(7): 987–994.
Huff, M A. Medical applications of micro-electro-mechanical-systems. In: Rosen, Y, Elman, N (Eds.), Biomaterials Science: An Integrated Clinical and Engineering Approach: Boca Raton, FL: CRC Press, 2012: pp. 30–84.
Jarow, J P, Baxley, J H. Medical devices: US medical device regulation. Urol Oncol 2015; 33(3): 128–132.
Kaplan, A V, Baim, D S, Smith, J J, et al. Medical device development: from prototype to regulatory approval. Circulation 2004; 109(25): 3068–3072.
Kaplan, A V, Harvey, E D, Kuntz, R E, et al. Humanitarian use devices/humanitarian device exemptions in cardiovascular medicine. Circulation 2005; 112(18): 2883–2886.
Mehta, S S. Commercializing Succesful Biomedical Technologies. Cambridge: Cambridge University Press, 2008.
Orbach, B. What is regulation? Yale Journal on Regulation 2012; 30(1): 1–10.
Robertson, G. Crimes Against Humanity: The Struggle for Global Justice. New York, NY: The New Press, 2006.
Rome, B N, Kramer, D B, Kesselheim, A S. Approval of high-risk medical devices in the US: implications for clinical cardiology. Curr Cardiol Rep. 2014; 16(6): 489.
Saviola, J. The FDA role in medical devices clinical studies of human subjects. J Neural Eng 2005; 2: S1–S4.
Schuh, J C. Medical device regulations and testing for toxicological pathologists. Toxicol Pathol 2008; 36(1): 63–69.
Smith, J J. Off-label use of medical devices in radiology: regulatory standards and recent developments. J Am Coll Radiol 2010; 7(2): 115–119.
Smith, J J, Berlin, L. Off-label use of interventional medical devices. AJR Am J Roentgenol 1999; 173(3): 539–542.
Starnes, B W. A surgeon’s perspective regarding the regulatory, compliance, and legal issues involved with physician-modified devices. J Vasc Surg 2013; 57: 829–831.
Sweet, B V, Schwemm, A K, Parsons, D M. Review of the processes for FDA oversight of drugs, medical devices, and combination products. J Manag Care Pharm 2011; 17(1): 40–50.
Thomadsen, B R, Heaton, H T II, Jani, S K, et al. Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121. Med Phys 2010; 37(5): 2301–2309.
van Eck, C F, Chen, A F, Klatt, B A, D’Antonio, J, Fu, F. The classification of implants: class I, II, III. J Long Term Eff Med Implants 2009; 19(3): 185–193.
World Health Organization. Medical Device Regulations. Global overview and guiding principles. Geneva: World Health Organization, 2003.
Wizemann, T, ed. Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report. Washington, DC: National Academy of Sciences, 2011.